Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2002
09/11/2002EP1237561A2 Use of honey in medical dressings
09/11/2002EP1237560A2 Regenerative adjuvant (3-way tap)
09/11/2002EP1237548A1 Il-8 receptor antagonists
09/11/2002EP1237536A1 The use of fluorescent whitening agents
09/11/2002EP1237532A2 Ultraviolet radiation absorbing waxes useful in cosmetic compositions
09/11/2002EP1237420A2 Reduced calorie fat compositions
09/11/2002EP1190024B1 Grapeseed, cold-pressed grape oil, crushed grape and grape flour
09/11/2002EP1047732B1 Color shifting film glitter
09/11/2002EP0824348B1 Treatment of psoriasis with 11-cis-retinoic acid
09/11/2002EP0809493B1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
09/11/2002EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
09/11/2002EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
09/11/2002CN1369015A Recombinant anti-CD 40 antibody and uses thereof
09/11/2002CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties
09/11/2002CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor
09/11/2002CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase
09/11/2002CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
09/11/2002CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application
09/11/2002CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha
09/11/2002CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
09/11/2002CN1368950A Novel aminobenzophenones
09/11/2002CN1368946A New selective retinoid agonists
09/11/2002CN1368892A Sustained release formulation of peptide
09/11/2002CN1368883A Method for reducing serum glucose and trigluceride and inhibiting vascular formation by indolealkanoic acids
09/11/2002CN1368378A Efficient medicine for treating foot tinea and berberi
09/11/2002CN1368353A Nano medicine 'Zibushengfa' and its preparing process
09/11/2002CN1368320A Nano medicine 'Shengerfa' and its preparing process
09/11/2002CN1368277A Nano medicine 'Yujin Yinxie' and its preparing process
09/11/2002CN1368272A Nano medicine 'Zhengjin' and its preparing process
09/11/2002CN1368238A Nano medicine for reducing fat and growing hair and its preparing process
09/11/2002CN1368235A Nano medicine for treating leukoderma and its preparing process
09/11/2002CN1368194A Nano medicine 'Compound Zhenzhu Anchuan' and its praparing process
09/11/2002CN1368179A Nano medicine 'Shexiangqutong' and its preparing process
09/11/2002CN1368178A Nano medicine 'Shaoshangling' and its preparing process
09/11/2002CN1368149A Nano medicine 'Gushen Shengfa' and its preparing process
09/11/2002CN1368138A Nano safflower medicine and its preparing process
09/11/2002CN1368134A Nano medicine 'Sisheng' and its preparing process
09/11/2002CN1368109A Nano medicinig for nourishing blood and growing hair and its preparing process
09/11/2002CN1368099A Nano medicine 'Xiaoyin' and its preparing process
09/11/2002CN1368083A Nano medicine 'Pianzaihuang' and its preparing process
09/11/2002CN1368073A Nano medicine 'Ziyun' and its preparing process
09/11/2002CN1368051A Composite medicine for treating dermatopathy
09/11/2002CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition
09/11/2002CN1090505C 多功能酶 Multifunctional enzyme
09/11/2002CN1090497C Medicine for treating burn
09/11/2002CN1090496C External-use medicine for treating superficial skin fungus disease
09/11/2002CN1090495C Jieyinjing washing liquid for cleaning pudendum and preparation method thereof
09/11/2002CN1090492C Ointment for treating skin tinea
09/11/2002CN1090485C Psoriasis resisting capsule and its preparation method
09/11/2002CN1090473C Face skin-care oil
09/10/2002US6448382 Loading a mixture of isoforms onto a tsk sulfopropyl cation exchange chromatography column, washing with linear gradient buffer, discarding fraction comprising double clipped isoform and collecting intact and single-clipped isoforms
09/10/2002US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease
09/10/2002US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia
09/10/2002US6448284 Substituted tricyclics
09/10/2002US6448277 VEGF receptor tyrosine kinase inhibitors
09/10/2002US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor
09/10/2002US6448272 Myt1 kinase inhibitors
09/10/2002US6448271 Substituted benzimidazoles and their use as parp inhibitors
09/10/2002US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
09/10/2002US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?)
09/10/2002US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases
09/10/2002US6448233 System for dispensing benzoyl peroxide and macrolide or aminoglycoside antibiotic for treatment of acne wherein each is present in a high concentration and dispensing causes mixing to achieve desired concentration for topical use
09/10/2002US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation
09/10/2002US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells
09/10/2002US6448036 ribB
09/10/2002US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer
09/10/2002US6447815 Heated alcohol extraction of herbs
09/10/2002US6447790 Oily material composition
09/10/2002US6447787 Methods for enhancing wound healing
09/10/2002US6447782 Lipid extract of the Skeletonema algae
09/10/2002US6447762 Mixture containing extracts of hops, rosemary and swertia and silanodiol salicylate
09/06/2002WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/06/2002WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
09/06/2002WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
09/06/2002WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases
09/06/2002WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
09/06/2002WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis
09/06/2002WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
09/06/2002WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
09/06/2002WO2002068389A2 Indole derivatives with inhibitor effects on phenol oxidase
09/06/2002WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/06/2002WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto
09/06/2002WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
09/06/2002WO2002067988A2 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
09/06/2002WO2002067986A2 Symbiotic regenerative agent
09/06/2002WO2002067950A1 Vascular regeneration promoters
09/06/2002WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002WO2002067919A1 Il-8 receptor antagonists
09/06/2002WO2002067900A1 Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same
09/06/2002WO2002067897A2 In-situ gel formation of pectins
09/06/2002WO2002067891A1 Free nicotine based cosmetic composition and uses thereof
09/06/2002WO2002067880A1 Treatment of dandruff
09/06/2002WO2002067879A2 Material composition and oral galenic form against hair loss and brittle nails
09/06/2002WO2002067873A2 Method for suppressing reduction of elasticity of skin
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/06/2002WO2002067848A2 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE